Cenobamate and Clobazam interaction

Cenobamate and Clobazam: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.

Moderate

Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.

What the FDA labels say

From the Cenobamate (Xcopri) label · effective 2025-08-25

Moderate

Phenobarbital and Clobazam: Reduce dosage as needed when used concomitantly with XCOPRI.

Drug interactionsnames ClobazamView label on DailyMed
Moderate

…phenobarbital ↑ plasma concentrations Because of a potential for an increase in the risk of adverse reactions from these drugs, consider a reduction in dosage of phenobarbital or clobazam, as clinically appropriate, when used concomitantly with XCOPRI. desmethylclobazam, the active metabolite of clobazam ↑ plasma concentrations CYP2B6 Substrates ↓ plasma concentrations…

Drug interactionsnames ClobazamView label on DailyMed
Moderate

Concomitant use with other CNS depressants or alcohol may have additive effects.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Anyone considering prescribing XCOPRI or any other AED must balance this risk with the risk of untreated illness.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Patients should be carefully observed for signs of central nervous system (CNS) depression, such as somnolence and sedation, when XCOPRI is used with other drugs with sedative properties because of potential additive effects.

Warnings and precautionsby drug classView label on DailyMed

From the Clobazam (SYMPAZAN) label · effective 2025-12-01

Moderate

Risk may be increased with concomitant use of other CNS depressants ( 5.4 , 5.5 )

Warnings and precautionsby drug classView label on DailyMed
Moderate

Prescribers should monitor patients for somnolence and sedation, particularly with concomitant use of other central nervous system depressants.

Warnings and precautionsby drug classView label on DailyMed
Moderate

Strong or Moderate CYP2C19 Inhibitors: Dosage adjustment of SYMPAZAN ® may be necessary ( 7.4 )

Drug interactionsby drug classView label on DailyMed
Moderate

Therefore, caution patients or their caregivers against simultaneous use with other CNS depressant drugs or alcohol, and caution that the effects of other CNS depressant drugs or alcohol may be potentiated [see Warnings and Precautions (5.4) ].

Drug interactionsby drug classView label on DailyMed
Moderate

Effect of Other Drugs on SYMPAZAN ® Strong and Moderate Inhibitors of CYP2C19 Coadministration with strong or moderate inhibitors of CYP2C19 may result in increased exposure to N-desmethylclobazam, the active metabolite of clobazam.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.